1. Home
  2. HIMS vs KRYS Comparison

HIMS vs KRYS Comparison

Compare HIMS & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hims & Hers Health Inc.

HIMS

Hims & Hers Health Inc.

HOLD

Current Price

$27.31

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$279.25

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIMS
KRYS
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.8B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
HIMS
KRYS
Price
$27.31
$279.25
Analyst Decision
Hold
Strong Buy
Analyst Count
15
11
Target Price
$30.46
$297.60
AVG Volume (30 Days)
28.2M
200.8K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
0.51
1.83
Revenue
$2,347,637,000.00
$389,130,000.00
Revenue This Year
$19.82
$38.74
Revenue Next Year
$19.23
$32.53
P/E Ratio
$53.55
$38.87
Revenue Growth
59.00
33.94
52 Week Low
$13.74
$123.03
52 Week High
$70.43
$298.30

Technical Indicators

Market Signals
Indicator
HIMS
KRYS
Relative Strength Index (RSI) 56.43 61.33
Support Level $18.62 $254.53
Resistance Level $27.54 $293.60
Average True Range (ATR) 2.34 10.66
MACD -0.14 0.07
Stochastic Oscillator 57.12 98.66

Price Performance

Historical Comparison
HIMS
KRYS

About HIMS Hims & Hers Health Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: